Cost-effective treatment of low-risk carcinoma not invading bladder muscle.
about
The health economics of bladder cancer: an updated review of the published literature.Health-care services utilization and costs associated with radical cystectomy for bladder cancer: a descriptive population-based study in the province of Quebec, Canada.Detection of specific chromosomal aberrations in urine using BCA-1 (oligo-CGH-array) enhances diagnostic sensitivity and predicts the aggressiveness of non-muscle-invasive bladder transitional cell carcinoma.Budget impact of incorporating one instillation of hexaminolevulinate hydrochloride blue-light cytoscopy in transurethral bladder tumour resection for patients with non-muscle-invasive bladder cancer in Sweden.Comparative effectiveness of transurethral resection of bladder tumors and office fulguration for recurrent bladder tumors.
P2860
Cost-effective treatment of low-risk carcinoma not invading bladder muscle.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Cost-effective treatment of low-risk carcinoma not invading bladder muscle.
@en
Cost-effective treatment of low-risk carcinoma not invading bladder muscle.
@nl
type
label
Cost-effective treatment of low-risk carcinoma not invading bladder muscle.
@en
Cost-effective treatment of low-risk carcinoma not invading bladder muscle.
@nl
prefLabel
Cost-effective treatment of low-risk carcinoma not invading bladder muscle.
@en
Cost-effective treatment of low-risk carcinoma not invading bladder muscle.
@nl
P2093
P2860
P1433
P1476
Cost-effective treatment of low-risk carcinoma not invading bladder muscle.
@en
P2093
Bilal Chughtai
David A Green
Douglas S Scherr
Evanguelos Xylinas
Michael Rink
Richard K Lee
Shahrokh F Shariat
P2860
P304
P356
10.1111/J.1464-410X.2012.11454.X
P433
P577
2012-09-07T00:00:00Z